Seminar: «Current topics in Pharmacology and Theranostics»

Seminarraum INO-F 703, Institut für Pharmakologie

Datum Zeit Name   Titel Gastgeber 
July 9, 2024 11:00 Dr. Collado Diaz Victor, Institute of Pharmaceutical Sciences, ETH Zurich Cardiovascular Toxicity in Chronic Therapies: The Role of P2X7 Receptors in Health and Disease G. Konstantinidou
Mar 6, 2024
12:15 Prof. Dr. Pablo Sinues, University Children's Hospital Basel, University of Basel, Basel  Pharmacometabolomics guided by breath analysis V. van der Velpen
Nov 15, 2023
12:15 Prof. Dr. med. Dagmar Meyer zu Heringdorf, Pharmazentrum Frankfurt, Frankfurt am Main News in cellular Ca2+ signalling by sphingosine 1-phosphate A. Huwiler
Nov 1, 2023
12:15 PD Dr. med. Tatiana Bremova-Ertl, Universitätsklinik für Neurologie, Inselspital, Bern N-Acetyl-L-Leucine: A symptomatic drug with neuroprotective potential? A. Huwiler
Oct 25, 2023
12:15 Prof. Dr. Özlem Tastan Bishop, Research Unit in Bioinformatics (RUBi), Department of Biochemistry and Microbiology, Rhodes University, Grahamstown/Makhanda, 6139, South Africa Proteins and missense mutations in health and disease C. Largiadèr
Oct 18, 2023
12:15 Prof. Dr. med. Pier Paolo Scaglioni, Division of Hematology Oncology, University of Cincinnati, USA Lipid metabolism regulates ferroptosis in lung cancer G. Konstantinidou
Oct 11, 2023
12:15 PD Dr. med. Tatiana Bremova-Ertl, Universitätsklinik für Neurologie, Inselspital, Bern N-Acetyl-L-Leucine: A symptomatic drug with neuroprotective potential?
A. Huwiler
Sept 14, 2023
13:30 Prof. Matej Orešič, Örebro University, Sweden Metabolome and exposome in metabolic dysfunction associated steatotic liver disease. Place: Microscopy- lecture hall, Pathology M. Masoodi
June 22, 2023
12:15 Dr. Gergely Gyimesi, Department of Biomedical Research/Nephrology, University of Bern SLC Atlas: towards a unified view
A. Huwiler
Mar 15, 2023
12:15 Prof. Dr. Manuele Rebsamen, Department of Immunobiology, University of Lausanne Solute carriers in metabolism and (auto)immunity: molecular mechanisms and therapeutic potential G. Konstantinidou
Mar 14, 2'23
12:15 Prof. Dr. Andreas Strasser, The Walter and Eliza Hall Institute of Medical Research (WEHI), Melbourne, Australia How does the tumour suppressor p53 prevent the development of cancer? T. Kaufmann
Feb 28, 2023
14:00 Prof. Rami Aqeilan, Lautenberg Center for Immunology and Cancer Research, Hebrew University – Hadassah Medical School, Jerusalem, Israel Non-canonical roles for long and fragile genes in cancer and neuropathologies H-U Simon
Feb 1, 2023
12:15 PD Dr. Stephan Kellenberger, Department of Biomedical Sciences, University of Lausanne Cellular roles and molecular mechanisms of acid-sensing ion channels A. Huwiler
Jan 18, 2023 12:15 Prof. Dr. Patrycja Nowak-Sliwinska, Institute of Pharmaceutical Sciences, University of Geneva Why one drug is not enough? G. Konstantinidou
Dec 19, 2022 12:15 Dr. Anna Brichkina, Center for Tumor Biology and Immunology, Philipps University of Marburg, Germany Targeting the tumor stroma: new concepts and potential approaches H-U Simon
Oct 12, 2022
12:15 Prof. Dr. Wolfgang Eberhardt, Pharmazentrum Frankfurt/ZAFES, Goethe University Frankfurt am Main Multifaceted roles of the E3 Liagase TRIM25 in colorectal cancer
A. Huwiler
Sept 21, 2022
12:15 Prof. Dr. med. Britta Maurer, Universitätsklinik für Rheumatologie und Immunologie, Inselspital, Bern Predictive potential of the integration of multi-source molecular data and imaging-based radiomic data in (experimental) fibrosing ILD S. von Gunten
July 6, 2022
12:15 Priv. Doz. Dr. Gabriele Weitz-Schmidt, AlloCyte Pharmaceuticals AG, Basel Integrin targeting pharmacology – The mechanism of action matter A. Huwiler
April 13, 2022
12:15 Dr. Michaela Medova, Department for BioMedical Research, University of Bern METworks - at the interface between radioresistance and behavior G. Konstantinidou
Jan 19, 2022
12:15 Prof. Dr. Sebastian Leidel, Department of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern RNA modifications and disease: Cause or cure? A. Huwiler

Unterstützt durch:

 GSK, Münchenbuchsee